Generate Investment Management Trims McKesson Stake

Asset manager reduces holdings in pharmaceutical distributor by 80%

Mar. 28, 2026 at 10:28am

Got story updates? Submit your updates here. ›

Generate Investment Management Ltd. trimmed its stake in McKesson Corporation (NYSE: MCK) by 80.4% during the fourth quarter, according to a recent SEC filing. The fund now owns 3,972 shares of the pharmaceutical distribution company's stock, down from 20,267 shares previously.

Why it matters

This reduction in holdings by Generate Investment Management, a prominent asset manager focused on sustainable investing, could signal broader concerns about McKesson's long-term prospects or a shift in the firm's investment strategy. McKesson is one of the largest pharmaceutical distributors in the U.S., making it a bellwether for the healthcare supply chain.

The details

According to the 13F filing, Generate Investment Management sold 16,295 shares of McKesson during the fourth quarter, leaving it with a much smaller position in the company. The firm's holdings in McKesson were valued at $3.26 million as of the end of 2025.

  • Generate Investment Management filed its 13F report for the fourth quarter of 2025 on March 28, 2026.
  • The firm reduced its McKesson stake during the three-month period ending December 31, 2025.

The players

Generate Investment Management Ltd

A global asset management firm focused on sustainable and responsible investing.

McKesson Corporation

One of the largest pharmaceutical distributors in the United States, supplying drugs and medical-surgical supplies to healthcare providers.

Got photos? Submit your photos here. ›

What they’re saying

“We must remain vigilant in our efforts to invest in companies that are aligned with our sustainability principles.”

— David Blood, Co-founder, Generate Investment Management

What’s next

Investors will be watching to see if other major institutional holders of McKesson stock make similar moves in the coming quarters, which could signal broader concerns about the company's direction.

The takeaway

This reduction in holdings by a prominent sustainable investing firm highlights the growing importance of environmental, social, and governance (ESG) factors in the healthcare sector, as investors scrutinize the practices and long-term viability of major industry players.